semaglutide getting banned Compounded Ban Status & What Patients Should Know – PlexusDx 1 in 4 Medicare beneficiaries

an investigation into N-terminally constrained analogues of glucagon-like peptide 1 (GLP-1) and Exendin-4

They have proved highly effective in driving LDL cholesterol numbers down in several groups of patients at high risk of having first or repeat heart attacks or strokes

But the daily experience of each form is very different

Treatment effect appears to peak at 8 mg weekly of Retatrutide.At 48 weeks of treatment, patients on highest Retatrutide dose of 12 mg lost 24% of their total body weight (compared to 2% in the placebo group)!Even at 24 weeks of treatment, patients on 12 mg of Retatrutide lost almost 18% of their total body weight (compared to 2% in placebo)This triple-hormone-receptor agonist might be the future of obesity treatment